Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Toll-like receptor 4 (TLR4) mRNA 3' untranslated region (UTR) is a critical regulatory segment of the TLR4 transcript that governs the stability and translation of the receptor protein. TLR4 is a central component of the innate immune system, primarily responsible for recognizing lipopolysaccharides (LPS) from Gram-negative bacteria and initiating inflammatory signaling pathways (Taganov et al., PNAS 2006). The 3' UTR contains multiple binding sites for microRNAs (miRNAs), such as miR-146a and miR-223, and RNA-binding proteins that act as post-transcriptional rheostats to prevent excessive inflammation (He et al., 2014). Dysregulation of these regulatory interactions is linked to chronic inflammatory conditions, sepsis, and neuropathic pain, where over-expression of TLR4 drives pathological cytokine storms. Therapeutic strategies targeting this region, such as miRNA mimics or antisense oligonucleotides, aim to downregulate TLR4 expression to mitigate pathological inflammation. Consequently, the TLR4 mRNA 3' UTR represents a high-value target for precision modulation of the immune response in various inflammatory and autoimmune contexts.
Modulation of mRNA stability and translational efficiency through competitive binding or recruitment of the RNA-induced silencing complex (RISC) to reduce TLR4 protein synthesis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toll-like receptor 4 messenger RNA 3' untranslated region (TLR4 mRNA 3' UTR).